Drug Shortages, Pricing, and Regulatory Activity
NBER Working Paper No. 22912 ---- Acknowledgments ---- I would like to thank David Kreling, Ernie Berndt, Rena Conti, Neeraj Sood, and other participants in the NBER-CRIW workshop (October, 2013) for their helpful comments on an earlier draft of this paper. I would also like to thank Erin Fox at the University of Utah Drug Information Service for kindly offering me data on shortages. Finally I would like to thank Eric Barrette for his research assistance on aspects of this paper. The views expressed herein are those of the author and do not necessarily reflect the views of the National Bureau of Economic Research. |

Contact Us









